0.4871

1.24% -0.0061

Cue Biopharma Inc (CUE)

Overview News Price History Option Chain Financials Discussions Forecast

Cue Biopharma Inc stock is traded at $0.4871, with a volume of 395.99K. It is down -1.24% in the last 24 hours and down -27.04% over the past month. Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

Previous Close:

$0.4932

Open:

$0.4858

24h Volume:

395.99K

Relative Volume:

1.36

Market Cap:

$38.35M

Revenue:

$9.53M

Net Income/Loss:

$-44.61M

P/E Ratio:

-0.5353

EPS:

-0.91

Net Cash Flow:

$-38.32M

1W Performance:

-11.24%

1M Performance:

-27.04%

6M Performance:

-23.38%

1Y Performance:

-53.39%

1-Day Range:

$0.4662

$0.5069

1-Week Range:

$0.4662

$0.55

52-Week Range:

$0.4662

$1.75

Cue Biopharma Inc Stock (CUE) Company Profile

Name

Cue Biopharma Inc

Sector

Healthcare (1123)

Industry

Biotechnology (627)

Phone

617-949-2680

Address

40 GUEST STREET, BOSTON, MA

Employee

Twitter

@cuebiopharma

Next Earnings Date

2025-03-31

Latest SEC Filings

CUE's Discussions on Twitter

Compare CUE with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CUE Cue Biopharma Inc	0.4871	38.83M	9.53M	-44.61M	-38.32M	-0.91
VRTX Vertex Pharmaceuticals Inc	452.04	113.14B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	741.29	78.49B	14.25B	4.58B	3.88B	41.77
ARGX Argen X Se Adr	877.94	54.76B	3.06B	1.28B	447.35M	19.67
ALNY Alnylam Pharmaceuticals Inc	397.55	54.51B	3.21B	43.57M	221.36M	0.2405
INSM Insmed Inc	197.01	41.64B	447.02M	-1.18B	-906.14M	-6.1812

Cue Biopharma Inc Stock (CUE) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-13-24	Initiated	Jefferies	Buy
Jun-26-23	Resumed	Oppenheimer	Outperform
Nov-21-22	Initiated	Piper Sandler	Overweight
Jan-13-22	Initiated	H.C. Wainwright	Buy
Jan-03-22	Initiated	Craig Hallum	Buy
Nov-24-20	Initiated	Berenberg	Buy
Apr-09-20	Initiated	Stifel	Buy
Jan-28-20	Initiated	BTIG Research	Buy
Jan-22-20	Initiated	JMP Securities	Mkt Outperform

View All

Cue Biopharma Inc Stock (CUE) Latest News

Dec 10, 2025

Does Cue Biopharma Inc (CUE) offer a good opportunity for investors? - Setenews

Dec 10, 2025

Dec 05, 2025

Cue Biopharma (CUE) Price Target Increased by 25.00% to 5.10 - Nasdaq

Dec 05, 2025

Dec 04, 2025

Will Cue Biopharma Inc. stock continue upward momentum2025 Price Momentum & Fast Gain Stock Trading Tips - Newser

Dec 04, 2025

Is Cue Biopharma Inc. stock a safe investment in uncertain marketsDip Buying & Stepwise Trade Signal Implementation - Newser

Dec 04, 2025

How Cue Biopharma Inc. stock reacts to inflationary pressuresTrade Signal Summary & Real-Time Volume Triggers - Newser

Dec 04, 2025

Is Cue Biopharma Inc. (1UC) stock dividend growth reliableSwing Trade & Community Consensus Picks - Newser

Dec 04, 2025

Dec 03, 2025

Is Cue Biopharma Inc. (1UC) stock testing key supportStop Loss & Long-Term Safe Investment Ideas - Newser

Dec 03, 2025

Dec 02, 2025

What Wall Street predicts for Cue Biopharma Inc. stock price2025 Breakouts & Breakdowns & Safe Entry Zone Identification - Newser

Dec 02, 2025

Will Cue Biopharma Inc. (1UC) stock benefit from infrastructure billQuarterly Earnings Report & Long-Term Capital Growth Strategies - Newser

Dec 02, 2025

How Cue Biopharma Inc. (1UC) stock moves in volatile trading sessionsOil Prices & High Conviction Buy Zone Alerts - Newser

Dec 02, 2025

Nov 30, 2025

Can Cue Biopharma Inc. stock rebound after recent weakness2025 Volume Leaders & Technical Buy Zone Confirmation - BỘ NỘI VỤ

Nov 30, 2025

Nov 27, 2025

Is Cue Biopharma Inc (CUE) positioned for future growth? - Setenews

Nov 27, 2025

Nov 26, 2025

Will Cue Biopharma Inc. stock benefit from AI adoptionMarket Risk Summary & Community Supported Trade Ideas - moha.gov.vn

Nov 26, 2025

Nov 25, 2025

[Form 4] Cue Biopharma, Inc. Insider Trading Activity - Stock Titan

Nov 25, 2025

Nov 24, 2025

Cue Biopharma Releases Updated Corporate Presentation - TipRanks

Nov 24, 2025

[8-K] Cue Biopharma, Inc. Reports Material Event | CUE SEC FilingForm 8-K - Stock Titan

Nov 24, 2025

Nov 23, 2025